Mend
PrivateLast Round
Early Funding
Oct 9, 2026
Total Funding Raised
$16.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Mend operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was an Early Funding round in October 2026.
Mend is a life sciences company that develops clinical nutritional products and digital health solutions designed to support surgical recovery and improve patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Mental Health, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mend Comparables
Compare Mend with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeamlessMD | 85% | |
| Force Therapeutics | 83% | |
| eVisit | 78% |
For institutional investors. Book with your work email.
Mend Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 9, 2026 | ||||
| Early Funding | Feb 5, 2026 | ||||
| Series A | Jun 6, 2023 | ||||
| Seed | Dec 27, 2020 | ||||
| Seed | Jul 27, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mend Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Institute for Commercialization of Florida Technology | Seed |
| iSelect Fund | Series A |
| Cerity Partners Ventures | Series A |
| Touchdown Ventures | Series A |
| Colorcon Ventures | Series A |
| KEEN Growth Capital | Series A |
| S2G Investments | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 9, 2026
$1.5M raised in early funding.
- Sep 12, 2026
Monthly visitors increased 30% MoM.
For institutional investors. Book with your work email.
Mend Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mend's valuation, stock price, and market status.
Is Mend a public or private company?
Mend is a private company.
What is the current stock price of Mend?
Mend is a private company, so its shares have no public market price. Caplight tracks Mend's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mend worth (valuation)?
Valuation information for Mend is not publicly available.
Can I buy Mend stock?
Mend shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mend's last funding round?
Mend's most recent funding round was Early Funding on October 9, 2026.
Who are the main investors in Mend?
Key investors in Mend include S2G Investments, Backswing Ventures.
Will Mend IPO soon?
No public IPO plans have been announced for Mend.
How can I track Mend secondary market activity?
Caplight tracks bids, offers, and trades in Mend's shares on secondary markets.